Arteriosclerosis Obliterans: Clinical Trials

1 trial for Arteriosclerosis Obliterans, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow Arteriosclerosis Obliterans: new trials by email Literature Review of Arteriosclerosis Obliterans trials Research Report on Arteriosclerosis Obliterans

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia
ADRC injection, ADRC isolation, Liposuction - Critical Limb Ischemia, Arteriosclerosis Obliterans
Phase 1 / Phase 2UnknownCentral Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation92016-07-012016-08-12

Narrower conditions

Chronic Limb-Threatening Ischemia (1)  ·  Diabetic Angiopathies (1)  ·  Peripheral Arterial Disease (1)  ·  Thromboangiitis Obliterans (1)

Broader conditions

Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Atherosclerosis (1)  ·  Cardiovascular Diseases (1)  ·  Chronic Disease (1)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)  ·  Disease Attributes (1)  ·  Endocrine System Diseases (1)  ·  Ischemia (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Peripheral Vascular Diseases (1)  ·  Vascular Diseases (1)  ·  Vasculitis (1)

Interventions

Lipectomy (1)

Sponsors

Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation (1)

Countries

Russia (1)

Top investigators

Andrey A Kalinin, MD, PhD (1)  ·  Andrey A Pulin, MD, PhD (1)  ·  Evgeny R Lysenko, MD, PhD, Prof (1)